Evaluation of previously assigned antibody concentrations in pneumococcal polysaccharide reference serum 89SF by the method of cross- standardization

Clinical and Diagnostic Laboratory Immunology

Volumn 5, Issue 2, 1998, Pages 199-204

  Concepcion, Nelydia ^a   Frasch, Carl E ^a,b  

^a Center for Biologics Evaluation and Research   (United States)

^b Division of Bacterial Products   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN G ANTIBODY;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; REFERENCE VALUE; STANDARD; STREPTOCOCCUS PNEUMONIAE;

EID: 0031923834     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.5.2.199-204.1998     Document Type: Article

References (18)

1. Anonymous. 1995. Overcoming scientific and technical barriers: pneumococcal vaccines, p. 8-12. In G. W. Pearson (ed.), The children's vaccine initiative: continuing activities. National Academy Press, Washington. D.C.
2. Arakere, G., and C. E. Frasch. 1991. Specificity of antibodies to O-acetyl-positive and O-acetyl-negative group C meningococcal polysaccharides in sera from vaccinecs and carriers. Infect. Immun. 59:4349-4356.
3. Arakere, G., A. L. Lee, and C. E. Frasch. 1994. Involvement of phospholipid end groups of group C Neisseria meningitidis and Haemophilus influenzas type b polysaccharides in association with isolated outer membranes and in immunoassays. J. Bacteriol. 176:691-695.
4. Division of Microbiology and Infectious Diseases. 1995. The Jordan report-accelerated development of vaccines 1995, p. 18-21. National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
5. Frasch, C. E., J. M. Zahradnik, L. Y. Wang, L. F. Mocca, and C-M. Tsai, 1988. Antibody response of adults to an aluminum hydroxide-adsorbed Neisseria meningitidis serotype 2b protein-group B polysaccharide vaccine. J. Infect. Dis. 158:710-718.
6. Gheesling, L. L., G. M. Carlone, L. B. Pais, P. F. Holder, S. E. Maslanka, B. D. Plikaytis, M. Achtman, P. Densen, C. E. Frasch, H. Käyhty, J. P. Mays, L. Nencioni, C. Peelers, D. C. Phipps, J. T. Poolman, E. Rosenqvist, G. R. Siber, B. Thiesen, J. Tai, C. M. Thompson, P. P. Vella, and J. D. Wenger, 1994. Multicenter comparison of Neisseria meningitidis scrogroup C anticapsular polysaccharide antibody levels measured by a standardized enzymelinked immunosorhent assay. J. Clin. Microbiol. 32:1475-1482.
7. Kayhty, H., P.-R. Ronneberg, and J. Eskola. 1993. Tetravalent pneumococcal capsular polysaccharide-meningococcal outer membrane protein conjugale vaccine is immunogenic in early infancy, abstr. 175, p. 151. In Abstracts of the 33rd International Conference on Antimicrobial Agents and Chemotherapy American Society for Microbiology. Washington, D.C.
8. Koskela, M. 1997. Serum antibodies to pneumococcal C polysaccharidc in children: response to acute pneumococcal otitis media or to vaccination. Pediatr. Infect. Dis. J. 6:519-526.
9. Landesman, S. H., and G. Schiffman. 1981. Assessment of the antibody response to pneumococcal vaccinc in high-risk populations. Rev. Infect. Dis. 3:S184-S197.
10. Madore, D. V. Personal communication.
11. Nahm, M. H., G. R. Siber, and J. V. Olander. 1996. A modified Farr assay is more specific than ELISA for measuring antibodies to Streptococcus pneumoniae capsular polysaccharides. J. Infect. Dis. 173:113-118.
12. Peltola, H., H. Kayhty, M. Virtanen, and P. H. Makela. 1984. Prevention of Hacmophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine. N. Engl. J. Med. 310:1561-1566.
13. Plikaytis, B. D., S. H. Turner, L. L. Gheesling, and G. M. Carlone. 1991. Comparisons of standard curve-fitting methods to quantltatc Neisseria meningitidis group A polysaccharide antibody levels by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 29:1439-1446.
14. Quataert, S. A., C. S. Kirch, L. J. Quackenbush-Wiedl, D. C. Phipps, S. Strohmeyer, C. O. Cimino, J. Skuse, and D. V. Madore. 1995. Assignment of weight-based antibody units to a human antipncumococcal standard reference scrum, lot 89-S. Clin. Diagn. Lab. Immunol. 2:590-597.
15. 197 conjugate vaccine, abstr. 1082. Pediatr. Res. 39:138A.
16. Siber, G. R., C. Thompson, G. R. Reid, J. Almeido-Hill, B. Zacher, M. Wolff, and M. Santosham. 1992. Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease. J. Infect. Dis. 165:S129-S133.
17. Sorensen, U. B. S., J. Henrichscn, H.-C. Chen, and S. C. Szu. 1997. Covalent linkage between the capsular polysaccharide of streptococcus pneumoniae revealed by immunochemical methods. Microb. Pathog. 8:325-334.
18. Zangwill, K. M., C. M. Vadheim, A. M. Vannier, L. S. Hemenway, D. P. Greenberg, and J. I. Ward. 1996. Epidemiology of invasive pneumococcal disease in Southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial. J. Infect. Dis. 174:752-759.